| Literature DB >> 30142205 |
Letian Song1, Jean-Paul Ouedraogo1, Magdalena Kolbusz1, Thi Truc Minh Nguyen1, Adrian Tsang1.
Abstract
As a powerful tool for fast and precise genome editing, the CRISPR/Cas9 system has been applied in filamentous fungi to improve the efficiency of genome alteration. However, the method of delivering guide RNA (gRNA) remains a bottleneck in performing CRISPR mutagenesis in Aspergillus species. Here we report a gRNA transcription driven by endogenous tRNA promoters which include a tRNA gene plus 100 base pairs of upstream sequence. Co-transformation of a cas9-expressing plasmid with a linear DNA coding for gRNA demonstrated that 36 of the 37 tRNA promoters tested were able to generate the intended mutation in A. niger. When gRNA and cas9 were expressed in a single extra-chromosomal plasmid, the efficiency of gene mutation was as high as 97%. Co-transformation with DNA template for homologous recombination, the CRISPR/Cas9 system resulted ~42% efficiency of gene replacement in a strain with a functioning non-homologous end joining machinery (kusA+), and an efficiency of >90% gene replacement in a kusA- background. Our results demonstrate that tRNA promoter-mediated gRNA expressions are reliable and efficient in genome editing in A. niger.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30142205 PMCID: PMC6108506 DOI: 10.1371/journal.pone.0202868
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Functional testing of 37 tRNA promoters and terminators in CRISPR/cas9 genome editing.
| tRNA promoter | Length of tRNA gene (bp) | Length of intron (bp) | Anticodon | Length of tRNA promoter (bp) | Length of tRNA terminator (bp) | Number of total colonies in transformation plates | Number of white colonies ( |
|---|---|---|---|---|---|---|---|
| tRNAAla5 | 72 | 0 | AGC | 172 | 16 | 88 | 9 |
| tRNAAla23 | 72 | 0 | AGC | 172 | 7 | 36 | 2 |
| tRNAArg8 | 72 | 0 | ACG | 172 | 9 | 96 | 12 |
| tRNAArg21 | 72 | 0 | ACG | 172 | 9 | 71 | 8 |
| tRNAAsp2 | 91 | 19 | GTC | 191 | 18 | 124 | 12 |
| tRNAAsp5 | 90 | 18 | GTC | 190 | 11 | 65 | 2 |
| tRNACys1 | 72 | 0 | GCA | 172 | 11 | 100 | 7 |
| tRNACys2 | 72 | 0 | GCA | 172 | 15 | 72 | 5 |
| tRNAGln1 | 72 | 0 | CTG | 172 | 16 | 72 | 6 |
| tRNAGln2 | 92 | 20 | TTG | 192 | 20 | 102 | 6 |
| tRNAGlu1 | 72 | 0 | TTC | 172 | 17 | 56 | 4 |
| tRNAGlu12 | 71 | 0 | TTC | 171 | 16 | 63 | 3 |
| tRNAGly5 | 71 | 0 | GCC | 171 | 26 | 68 | 0 |
| tRNAGly13 | 71 | 0 | GCC | 171 | 16 | 34 | 3 |
| tRNAHis2 | 84 | 12 | GTG | 184 | 42 | 62 | 4 |
| tRNAHis3 | 71 | 0 | GTG | 171 | 32 | 82 | 4 |
| tRNAIle4 | 74 | 0 | AAT | 174 | 16 | 60 | 3 |
| tRNAIle8 | 74 | 0 | AAT | 174 | 17 | 94 | 4 |
| tRNALeu6 | 111 | 27 | AAG | 211 | 17 | 148 | 8 |
| tRNALeu14 | 112 | 27 | AAG | 212 | 13 | 46 | 1 |
| tRNALys6 | 73 | 0 | CTT | 173 | 16 | 124 | 6 |
| tRNALys17 | 73 | 0 | CTT | 173 | 18 | 82 | 5 |
| tRNAMet4 | 72 | 0 | CAT | 172 | 15 | 84 | 2 |
| tRNAMet9 | 72 | 0 | CAT | 172 | 21 | 78 | 3 |
| tRNAPhe2 | 73 | 0 | GAA | 173 | 17 | 60 | 2 |
| tRNAPhe12 | 73 | 0 | GAA | 173 | 11 | 88 | 10 |
| tRNAPro1 | 91 | 19 | AGG | 191 | 17 | 57 | 7 |
| tRNAPro3 | 91 | 19 | AGG | 191 | 17 | 68 | 3 |
| tRNASer4 | 105 | 23 | GCT | 205 | 13 | 98 | 4 |
| tRNASer7 | 81 | 0 | AGA | 181 | 15 | 90 | 4 |
| tRNAThr5 | 73 | 0 | AGT | 173 | 15 | 46 | 4 |
| tRNAThr6 | 73 | 0 | AGT | 173 | 13 | 48 | 4 |
| tRNATyr3 | 88 | 13 | GTA | 188 | 22 | 63 | 6 |
| tRNATy7 | 88 | 13 | GTA | 188 | 21 | 42 | 2 |
| tRNAVal1 | 74 | 0 | CAC | 174 | 18 | 33 | 4 |
| tRNAVal4 | 96 | 23 | CAC | 196 | 25 | 45 | 1 |
| tRNAVal15 | 87 | 14 | TAC | 187 | 18 | 64 | 7 |
* The colonies number was from single transformations
Fig 1The schematic representation of tRNA-driven CRISPR/Cas9 system adapted for A. niger.
(A) The ANEp8-Cas9 plasmid used to express cas9 gene. (B) The construct of gRNA cassette and the ANEp8-Cas9-gRNA plasmid bearing both gRNA cassette and cas9 gene. The tRNA promoter is composed of a tRNA gene and 100 bp upstream sequences. Arrow indicates the start site of transcription. Abbreviations: bla, beta-lactamase gene conferring ampicillin resistance; pkiA Prom, promoter of the pyruvate kinase gene; glaA Term, terminator of the glucoamylase gene; NLS: nuclear localization signal.
Strains and plasmids used in this study.
| NRRL3 | Wild type | |
| N593 (ATCC 64973) | [ | |
| NRRL2270 (ATCC11414) | Citric acid producer | [ |
| NRRL2270 | Uridine auxotroph | This study |
| NRRL2270 | Uridine auxotroph and NHEJ deficient | This study |
| ANEp8-Cas9 | Extra-chromosomal | This study |
| ANEp8-Cas9-gRNAalbA | Extra-chromosomal | This study |
| ANEp8-Cas9-gRNAolvA | Extra-chromosomal | This study |
| ANEp8-Cas9-gRNAglaA | Extra-chromosomal | This study |
Gene disruption rate mediated by using eleven different tRNA promoters in ANEp8-Cas9-gRNA plasmid.
| tRNA promoter | Gene disruption rate (%) | |
|---|---|---|
| tRNAAla5 | 93±2 | nd |
| tRNAArg21 | 92±2 | 97±1 |
| tRNAAsp5 | 96±1 | nd |
| tRNACys1 | 82±6 | 96±2 |
| tRNAGln2 | 15±6 | 13±2 |
| tRNALeu6 | 82±7 | 95±2 |
| tRNAPro1 | 93±1 | 88±2 |
| tRNATyr3 | 82±11 | nd |
| tRNAVal15 | 82±14 | nd |
| tRNAVal4 | 90±3 | nd |
| tRNAVal1 | 94±1 | nd |
The rate was calculated as the percentage of mutant colonies in all transformants. Results were based on triplicate transformations.
†nd: not determined.
Mutations generated by tRNA promoter-driven CRISPR/Cas9 mutagenesis.
| tRNA promoter | Target Gene | Mutant number | Deletion | Insertion | Mismatch |
|---|---|---|---|---|---|
| tRNAArg21 | 1 | 6 bp (+1 - +6) | |||
| 2 | 6 bp (+1 - +6) | ||||
| 3 | 4 bp (+1 - +4) | ||||
| 1 | 8 bp (+1 - +8) | ||||
| 2 | 612 bp (-11 - +429; +438 - + 609) | ||||
| 3 | 72 bp (-1 - +1) | ||||
| tRNACys1 | 1 | 27 bp (-27 - -1) | |||
| 2 | 854 bp (-854 - -1) | ||||
| 3 | 815 bp (-813 - +2) | 1 bp (T-817C) | |||
| 1 | 18 bp (+1 - +18) | ||||
| 2 | 10 bp (-2 - +8) | ||||
| 3 | 7 bp (-1 - +6) | ||||
| tRNAGln2 | 1 | 39 bp (-2 - -1) | |||
| 2 | 12 bp (-1 - +11) | ||||
| 3 | 22 bp (-22 - -1) | ||||
| 1 | 13 bp (-12 - +1) | ||||
| 2 | 1096 bp (-1038 - +58) | ||||
| 3 | 11 bp (-8 - +3) | ||||
| tRNALeu6 | 1 | 1 bp (-1) | |||
| 2 | 15 bp (-3 - +12) | ||||
| 3 | 979 bp (-979 - -1) | ||||
| 1 | 1 bp (-1) | ||||
| 2 | 88 bp (-1 - +4) | ||||
| 3 | 13 bp (-13 - -1) | ||||
| tRNAPro1 | 1 | 6 bp (-7 - -2) | |||
| 2 | 4 bp (-3 - +1) | 1 bp (A-6G) | |||
| 3 | 2 bp (-2 - -1) | ||||
| 1 | 1 bp (-1) | ||||
| 2 | 2 bp (-2 - -1) | ||||
| 3 | 1 bp (-1) |
The mutation locations are given in brackets. The Cas9 cleavage site is defined as 3 bp upstream of the PAM sequence and is designated position "0". The negative and positive coordinates indicate mutations locate at 5’ and 3’ to the position 0, respectively.
CRISPR/Cas9-mediated targeting homologous integration in A. niger.
| CRISPR plasmid | NHEJ competent strain ( | NHEJ deficient strain ( | |||||
|---|---|---|---|---|---|---|---|
| Total colonies | Orange colonies | Gene replacement mutants / Screened mutants | Total colonies | Orange colonies | Gene replacement mutants / Screened mutants | ||
| ANEp8-Cas9 | Yes | 125 ± 3 | 15 ± 1 | 0/9 | 75 ± 1 | 21 ± 5 | 6/9 |
| ANEp8-Cas9-gRNAglaA | Yes | 106 ± 4 | 80 ± 3 | 5/9 | 88 ± 7 | 82 ± 6 | 9/9 |
| ANEp8-Cas9-gRNAglaA | No | 98 ± 6 | - | - | 0 | - | - |
The value was calculated from duplicate independent transformations and the average is mentioned.
The mutant number was counted according to the phenotype of orange color in the primary transformants.
From each scenario, nine of the orange colored transformants were selected to screen for gene replacement by PCR.
Summary of CRISPR/Cas9-mediated gene mutation and replacement efficiencies in filamentous fungi.
| Organism | gRNA cassette components | Gene replacement rate (%) | Gene disruption rate (%) | Expression plasmid/other method | References | ||
|---|---|---|---|---|---|---|---|
| Promoter | Ribozyme splicing sequences | Terminator | |||||
| tRNA | No | tRNA | 42% or 93% | 13–15% or 82–97% | Extrachromosomal (AMA1) | This study | |
| Yes | 90% | 20–30% | Extrachromosomal (AMA1) | [ | |||
| Yes | 65% | > 70% | Extrachromosomal (AMA1) | [ | |||
| No | nd | 25–53% | Integrative | [ | |||
| No | 63% | 43% | Extrachromosomal (AMA1) | [ | |||
| No | nd | 10–20% | Integrative | [ | |||
| No | nd | nd | Integrative | [ | |||
| No | 36–84% | nd | Integrative | [ | |||
| 93–100% | nd | [ | |||||
| No | nd | 70–100% | Extrachromosomal (ARS) | [ | |||
| No | 100% | nd | Extrachromosomal (AMA1) | [ | |||
| Yes | 100% | nd | Extrachromosomal (AMA1) | [ | |||
| No | nd | 21% | Integrative | [ | |||
| No | 95% | nd | Integrative | [ | |||
| No | 90% | nd | Integrative | [ | |||
The value of 42% and 93% were obtained from experiments in A. niger kusA and kusA strains respectively using tRNAPro1 as gRNA cassette promoter.
The 13–15% correspond to tRNAGln2 promoter, and the 82–97% correspond to the other ten tRNA promoters as described in this study.
nd: not determined.